Method for alleviating side effects of retinoic acid therapy and/or improving efficacy without interfering with efficacy

Details for Australian Patent Application No. 2008219633 (hide)

Owner ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION

Inventors Jacobson, Myron K.; Kim, Hyuntae; Jacobson, Elaine L.; Coyle, Donna L.; Coyle, Russell

Agent Griffith Hack

Pub. Number AU-B-2008219633

PCT Pub. Number WO2008/106177

Priority 60/903,937 28.02.07 US

Filing date 27 February 2008

Wipo publication date 4 September 2008

Acceptance publication date 26 May 2011

International Classifications

A61K 31/21 (2006.01) - Esters, e.g. nitroglycerine, selenocyanates

Event Publications

17 September 2009 PCT application entered the National Phase

  PCT publication WO2008/106177 Priority application(s): WO2008/106177

26 May 2011 Application Accepted

  Published as AU-B-2008219633

22 September 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008219647-Hemodialysis systems and methods

2008219622-Methods for the treatment of liver diseases using specified matrix metalloproteinase (MMP) inhibitors